Growth Metrics

Quest Diagnostics (DGX) Cash from Investing Activities: 2009-2025

Historic Cash from Investing Activities for Quest Diagnostics (DGX) over the last 17 years, with Sep 2025 value amounting to -$201.0 million.

  • Quest Diagnostics' Cash from Investing Activities rose 87.69% to -$201.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$942.0 million, marking a year-over-year increase of 56.39%. This contributed to the annual value of -$2.5 billion for FY2024, which is 140.15% down from last year.
  • Latest data reveals that Quest Diagnostics reported Cash from Investing Activities of -$201.0 million as of Q3 2025, which was down 62.10% from -$124.0 million recorded in Q2 2025.
  • In the past 5 years, Quest Diagnostics' Cash from Investing Activities registered a high of $437.0 million during Q2 2021, and its lowest value of -$1.6 billion during Q3 2024.
  • In the last 3 years, Quest Diagnostics' Cash from Investing Activities had a median value of -$200.0 million in 2024 and averaged -$368.1 million.
  • Per our database at Business Quant, Quest Diagnostics' Cash from Investing Activities soared by 313.17% in 2021 and then crashed by 1,426.17% in 2024.
  • Quarterly analysis of 5 years shows Quest Diagnostics' Cash from Investing Activities stood at -$227.0 million in 2021, then increased by 23.35% to -$174.0 million in 2022, then soared by 34.48% to -$114.0 million in 2023, then slumped by 340.35% to -$502.0 million in 2024, then surged by 87.69% to -$201.0 million in 2025.
  • Its Cash from Investing Activities stands at -$201.0 million for Q3 2025, versus -$124.0 million for Q2 2025 and -$115.0 million for Q1 2025.